🎙️ We’re back with the sixteenth episode of Parkinson Weekly, hosted by Prof. Bas Bloem. In this episode, Bas discusses the Article of the Week: Mucuna pruriens in untreated Parkinson’s disease in sub-Saharan Africa: A 12-month, multicenter, randomized, controlled trial. He explores the study’s design, key findings, and what this important research tells us about alternative, accessible treatment options for Parkinson’s disease, particularly in under-resourced settings, as well as its broader...
All content for Parkinson Weekly is the property of Oruen CNS and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
🎙️ We’re back with the sixteenth episode of Parkinson Weekly, hosted by Prof. Bas Bloem. In this episode, Bas discusses the Article of the Week: Mucuna pruriens in untreated Parkinson’s disease in sub-Saharan Africa: A 12-month, multicenter, randomized, controlled trial. He explores the study’s design, key findings, and what this important research tells us about alternative, accessible treatment options for Parkinson’s disease, particularly in under-resourced settings, as well as its broader...
EP 3 - Article Of The Week: Episode 3: Exenatide once a week versus placebo as a potential disease modifying treatment for people with Parkinsons disease in the UK: a phase 2, multi centre, double-blind, parallel-group, randomised, placebo-controlled tria
Parkinson Weekly
10 minutes
3 months ago
EP 3 - Article Of The Week: Episode 3: Exenatide once a week versus placebo as a potential disease modifying treatment for people with Parkinsons disease in the UK: a phase 2, multi centre, double-blind, parallel-group, randomised, placebo-controlled tria
🎙️ We’re back with the third episode of Parkinson Weekly, hosted by Prof. Bas Bloem. This week’s Article of the Week explores an exciting area of research: “Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson’s disease in the UK: a phase 2, multi-centre, double-blind, parallel-group, randomised, placebo-controlled trial.” 👉 You can read the full article here: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)02808-3/fullte...
Parkinson Weekly
🎙️ We’re back with the sixteenth episode of Parkinson Weekly, hosted by Prof. Bas Bloem. In this episode, Bas discusses the Article of the Week: Mucuna pruriens in untreated Parkinson’s disease in sub-Saharan Africa: A 12-month, multicenter, randomized, controlled trial. He explores the study’s design, key findings, and what this important research tells us about alternative, accessible treatment options for Parkinson’s disease, particularly in under-resourced settings, as well as its broader...
